Skip to main content
Kevin Kuntz, MD, Psychiatry, Madison, WI

KevinDKuntzMD

Psychiatry Madison, WI

Associate Professor, Psychiatry, University of Wisconsin Medical School

Are you Dr. Kuntz?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 40 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    406 Science Dr
    Suite 110
    Madison, WI 53711
    Phone+1 608-238-4411
    Fax+1 608-287-5992

Summary

  • Dr. Kevin Kuntz, MD is a board certified psychiatrist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Vermont. He is affiliated with Rogers Behavioral Health and is an Associate Professor at University of Wisconsin Medical School.

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Psychiatry, 1990 - 1994
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1994 - 2025
  • VT State Medical License
    VT State Medical License 1990 - 1994
  • American Board of Psychiatry and Neurology Psychiatry

Press Mentions

  • Ziopharm Finds New CEO After Six-Month Search; CFO Transition at Lonza to Take Place in December
    Ziopharm Finds New CEO After Six-Month Search; CFO Transition at Lonza to Take Place in DecemberSeptember 3rd, 2021
  • Ribon Therapeutics Presents Additional Preclinical Data on Its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of Its Platform at the AACR 2020 Virtual Meeting II
    Ribon Therapeutics Presents Additional Preclinical Data on Its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of Its Platform at the AACR 2020 Virtual Meeting IIJune 22nd, 2020
  • Ribon Therapeutics Presents Preclinical Data from Its PARP7 and PARP14 Programs at AACR Virtual Meeting I
    Ribon Therapeutics Presents Preclinical Data from Its PARP7 and PARP14 Programs at AACR Virtual Meeting IApril 27th, 2020